本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Amneal Pharmaceuticals, Inc.

10.40
+0.02000.19%
盤後10.400.00000.00%18:59 EDT
成交量:121.31萬
成交額:1,260.06萬
市值:32.66億
市盈率:958.61
高:10.46
開:10.33
低:10.26
收:10.38
52周最高:10.46
52周最低:6.69
股本:3.14億
流通股本:1.69億
量比:0.68
換手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):0.0108
每股收益(LYR):-0.3783
淨資產收益率:-881.26%
總資產收益率:6.85%
市淨率:-29.13
市盈率(LYR):-27.49

資料載入中...

2025/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/02

重要事件披露

Form 8-K - Current report
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

重要事件披露

Form 8-K - Current report
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/15

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

重要事件披露

Form 8-K/A - Current report: [Amend]